Angiogenesis and platelets: The clot thickens further

Cardiovascular Research

Volumn 63, Issue 2, 2004, Pages 192-193

  Blann, Andrew D ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CYCLIC AMP; FIBRINOGEN RECEPTOR ANTAGONIST; SPHINGOSINE 1 PHOSPHATE; THROMBIN; THROMBOCYTE FACTOR 4; VASCULOTROPIN;

ANGIOGENESIS; CLINICAL RESEARCH; EDITORIAL; EXPERIMENTAL MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR RING;

ANIMALS; ARTERIOSCLEROSIS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; THROMBOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3142648894     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.05.007     Document Type: Editorial

References (18)

1. Libby P., Simon D.A. Inflammation and thrombosis: the clot thickens. Circulation. 103:2001;1718-1720
2. Massberg S., Brand K., Gruner S., et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196:2002;887-896
3. Gawaz M. Do platelets trigger atherosclerosis? Thromb. Haemost. 90:2003;971-972
4. Lip G.Y.H., Chin B.S.P., Blann A.D. Cancer and the pro-thrombotic state. Lancet Oncol. 3:2002;27-34
5. Pinedo H.M., Verheul H.M.W., D'Amato R.J., Folkman J. Involvement of platelets in tumour angiogenesis? Lancet. 352:1998;1775-1777
6. Banks R.E., Forbes M.A., Kinsey S.E., et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer. 77:1998;956-964
7. Arisato T., Hashiguchi T., Sarker K.P., et al. Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region. J. Thromb. Haemost. 1:2003;2589-2593
8. Caine G.J., Lip G.Y.H., Stonelake P.S., Ryan P., Blann A.D. Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma. Thromb. Haemost. 2004;. (in press)
9. Roselli M., Mineo T.C., Basili S., et al. Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation ands platelet activation markers. Thromb. Haemost. 89:2003;177-184
10. O'Brien E.R., Garvin M.R., Dev R., et al. Angiogenesis in human coronary artery plaques. Am. J. Pathol. 145:1994;883-894
11. Babiak A., Schumm A.M., Wangler C., et al. Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion. Cardiovasc. Res. 61:2004;789-795
12. Blann A.D., Belgore F.M., McCollum C.N., Silverman S., Lip P.L., Lip G.Y.H. Vascular endothelial growth factor and its receptor Flt-1 in the plasma of patients with coronary and peripheral atherosclerosis and type II diabetes. Clin. Sci. 102:2002;187-194
13. Flesich M., Billinger M., Eberli F.R., Garachemani A.R., Meier B., Seiler C. Physiologically assessed coronary collateral blood flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation. 100:1999;1945-1950
14. Heeschen C., Dimmeler S., Hamm C.W., et al. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation. 107:2003;524-530
15. Brill A., Elinav H., Varon D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc. Res. 63:2004;226-235
16. O'Kane P.D., Queen L.R., Ji Y., et al. Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment. Cardiovasc. Res. 59:2003;152-159
17. English D., Garcia J.G., Brindley D.N. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 49:2001;588-599
18. Benamouzig R., Deyra J., Martin A., et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology. 125:2003;328-336